Thyroidectomy is the gold widespread for the number one remedy of differentiated thyroid cancer (DTC). Subsequent radioactive iodine (RAI) ablation of the thyroid remnant is currently recommended only in selected cases: sufferers with tumors < 2 cm and distant metastases, and in those with tumors > 2 cm and one of the following risk elements: gross extra-thyroidal extension, age > forty five years, lymph node and remote metastases [1, 2]. Moreover, the literature facts suggest an overuse of RAI in low-chance DTC patients [3]. When RAI is administered in younger pre-menopausal girls, they are cautioned now not to conceive for six–12 months after remedy; ovarian publicity is expected to be one hundred forty mGy for an administered pastime of one hundred mCi [4]. RAI is diagnosed as being a commonplace reason of transient menstrual disorder, observed by using an increased serum gonadotropin awareness in up to 27% of women [5]. In addition, in RAI-handled ladies, the literature information file an multiplied variety of miscarriages [6] and a better incidence of early menopause